ARK Innovation is a poor bet because Cathie Wood's track record is horrible and she did not see AI coming, so there is little reason to believe she can see around the next corner. Investors still put a net $2.5B into the fund in a week. x.com 

ARK Innovation ETF is unlikely to ever regain its Covid highs relative to the Nasdaq 100. It just hit a fresh 52-week low against the Nasdaq 100 and is nearing an all-time relative low, while carrying one of the highest ETF expense ratios. Cathie Wood day-trades names in the fund and has badly underperformed the index for years while collecting hundreds of millions in fees. x.com 

Innovation stocks no longer move inversely to Treasury yields, and that is the bull case. After the 2022 inflation shock, yields and these stocks have climbed together because yields are being pushed up by stronger real growth, AI capex, fiscal supply and fading recession fears, the same forces that lift disruptors' expected cash flows. The risk is a shift to deficits plus slowing growth, which would bring the old inverse correlation back immediately. x.com  x.com 

ARK Innovation is the biggest scam in finance, collecting management fees whether or not its bets work. Per @NoLimitGains, the fund is down 45% on its Cerebras position in one month and has lost over $40 million on SpaceX. x.com 

ARK Genomic Revolution ETF holds several of 2026's top-performing stocks as its biggest positions. The signal to take profits will be when CNBC features Cathie Wood on TV, likely within one to two months, since CNBC tends to ring the bell at the top. x.com 

ARK Innovation ETF's bull case is drawing whale support, with $4M of bullish options flow rolling July $75 calls up and out to September $82 calls. Bulls got confirmation from a monthly tweezer off support, though hedgers remain active and the low now sits 14% away, so this is not a spot to chase. x.com  x.com 

The S&P 500's elevated P/E masks concentration in just a few stocks, making index exposure less appealing than selective stock picking for risk and reward. Its P/E is well above the ten-year median; digging into individual constituents looks more sensible than buying all 500. x.com 

These specialized ETFs justify high expense ratios because they do things investors can't do themselves. Some hold pre-IPO companies such as SpaceX and Anthropic; others offer active management that has beaten the S&P 500 since inception, hedge-fund-style sub-advised alpha, risk-managed leverage, income without NAV decay or income with upside, exposure to stocks investors can't buy directly, or a broad diversified portfolio in one click. x.com 

Low-cost growth ETFs can build serious wealth through exposure to the best companies and strongest trends, without managing individual stocks. A clean setup is a core of VOO or VTI, a growth tilt through SCHG, VUG or QQQM, and an aggressive tech tilt through VGT. The ranking is SCHG, VUG, QQQM, SPYG, VGT, MGK, then IWF, which is solid but costlier. Many overlap, so owning all adds little diversification, and growth-heavy funds can be hit hard by rising rates, tech selloffs or rotation to value. … Show more

New investors who think they missed the AI run can still build exposure diversified across AI layers, chosen on today's valuations and risk-reward. A suggested split is 20% each in Meta, NVIDIA and Broadcom, and 10% each in a DRAM memory ETF, TSMC, Nebius and Credo: 80% in established leaders and critical bottlenecks, 20% in faster-growing compute and networking names. It spans applications, GPUs, custom silicon, foundries, memory, networking and cloud, and most picks are founder-led. x.com  … Show more